ALLMedicine™ Guillain-barre Syndrome Center

Jun 16th, 2022 - Reference Range Characteristics of normal spinal fluid are below: [1, 2, 3, 4] Total volume: 150 mL Color: Colorless, clear, like water Pressure: < 20 cm H 2O Osmolarity at 37°C: 281 mOsm/L Specific gravity: 1.006 to 1.008 Acid-base balance: pH: 7...

Jun 16th, 2022 - Reference Range Characteristics of normal spinal fluid are below: [1, 2, 3, 4] Total volume: 150 mL Color: Colorless, clear, like water Pressure: < 20 cm H 2O Osmolarity at 37°C: 281 mOsm/L Specific gravity: 1.006 to 1.008 Acid-base balance: pH: 7...

Jun 16th, 2022 - Characteristics of normal spinal fluid are below:[1, 2, 3, 4] Total volume: 150 mL Color: Colorless, clear, like water Pressure: < 20 cm H 2O Osmolarity at 37°C: 281 mOsm/L Specific gravity: 1.006 to 1.008 Acid-base balance: pH: 7.28-7.32 Pco2: 47...

Jun 10th, 2022 - Pembrolizumab demonstrated durable antitumor activity in 233 patients with previously treated advanced microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors in the phase 2 multicohort KEYNOTE-158 (NCT026...

Jun 7th, 2022 - Neurologic complications can be seen in mild to severe COVID-19 with a higher risk in patients with severe COVID-19. These can occur as a direct consequence of viral infection or consequences of treatments. The spectrum ranges from non-life-threat...

Mar 16th, 2022 - Guillain-Barre syndrome (GBS) is an immune-mediated acute inflammatory peripheral neuropathy. The currently proven effective treatment methods include intravenous immunoglobulin and plasma exchange. In the clinical treatment process, the plasma so...

Feb 17th, 2022 - Background The incidence of sepsis has increased over the last four decades (1). Sepsis is a life-threatening condition that arises when the body's response to an infection injures its own tissues and organs. Severe sepsis and septic shock are amo...

Jan 25th, 2022 - This is research study to find out if a drug called ADCT-301 is safe and to look at how patients respond to the study drug after an allogeneic transplantation. ADCT-301 will be administered on Days 1, 8 and 15 with blood tests following study drug...

Jan 25th, 2022 - The purpose of this study is to determine if peripheral nerve ultrasound can be used as a supplemental tool to diagnose Guillain-Barre syndrome (GBS) in the acute setting and aid in prognostication.

Jan 19th, 2022 - Guillain-barre syndrome (GBS) is an acute immune-mediated polyneuropathy. Intravenous Gamma globulin is an effective therapy.Although high doses of gamma globulin are clinically effective, the patient's recovery and clinical prognosis vary. The es...

Feb 16th, 2022 - Tens of thousands more people in the UK could be living with neuromuscular disease (NMD) than previous estimates suggested, according to new research. A study in the journal PLOS ONE, which analysed millions of GP records, suggested that the preva...

Nov 2nd, 2021 - NEW YORK (Reuters Health) - An analysis of Medicare claims data found an increased risk of Guillain-Barre syndrome (GBS) following receipt of the recombinant zoster vaccine (RZV), confirming the same "signal" from the U.S. Centers for Disease Cont...

Oct 14th, 2021 - NEW YORK (Reuters Health) - Data from the vaccine adverse event reporting system (VAERS) show a potential "small but statistically significant safety concern" for the development of Guillain-Barre syndrome (GBS) after receipt of the Janssen/Johnso...

Sep 13th, 2021 - Several weeks ago, I received a call from my brother who, though not a health care professional, wanted me to know he thought the public was being too critical of scientists and physicians who “are giving us the best advice they can about COVID. P.

Jul 23rd, 2021 - (Reuters) - Europe's medicines regulator said on Thursday it had added a nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson's COVID-19 vaccine after it reviewed 108 cases reported worldwide....